169 related articles for article (PubMed ID: 33822716)
1. Excitation of medium spiny neurons by 'inhibitory' ultrapotent chemogenetics via shifts in chloride reversal potential.
Gantz SC; Ortiz MM; Belilos AJ; Moussawi K
Elife; 2021 Apr; 10():. PubMed ID: 33822716
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
Wei W; Ding S; Zhou FM
J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785
[TBL] [Abstract][Full Text] [Related]
3. High ethanol sensitive glycine receptors regulate firing in D1 medium spiny neurons in the nucleus accumbens.
Gallegos S; Muñoz B; Araya A; Aguayo LG
Neuropharmacology; 2019 Dec; 160():107773. PubMed ID: 31521620
[TBL] [Abstract][Full Text] [Related]
4. Distinct roles of synaptic and extrasynaptic GABAAreceptors in striatal inhibition dynamics.
Luo R; Partridge JG; Vicini S
Front Neural Circuits; 2013; 7():186. PubMed ID: 24324406
[TBL] [Abstract][Full Text] [Related]
5. Striatal Distribution and Cytoarchitecture of Dopamine Receptor Subtype 1 and 2: Evidence from Double-Labeling Transgenic Mice.
Ren K; Guo B; Dai C; Yao H; Sun T; Liu X; Bai Z; Wang W; Wu S
Front Neural Circuits; 2017; 11():57. PubMed ID: 28860974
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and preclinical evaluation of [
Nerella SG; Telu S; Liow JS; Jenkins MD; Zoghbi SS; Gomez JL; Michaelides M; Eldridge MAG; Richmond BJ; Innis RB; Pike VW
Sci Rep; 2024 Jan; 14(1):1886. PubMed ID: 38253691
[TBL] [Abstract][Full Text] [Related]
7. Loss of BDNF signaling in D1R-expressing NAc neurons enhances morphine reward by reducing GABA inhibition.
Koo JW; Lobo MK; Chaudhury D; Labonté B; Friedman A; Heller E; Peña CJ; Han MH; Nestler EJ
Neuropsychopharmacology; 2014 Oct; 39(11):2646-53. PubMed ID: 24853771
[TBL] [Abstract][Full Text] [Related]
8. Differential dopaminergic regulation of inwardly rectifying potassium channel mediated subthreshold dynamics in striatal medium spiny neurons.
Zhao B; Zhu J; Dai D; Xing J; He J; Fu Z; Zhang L; Li Z; Wang W
Neuropharmacology; 2016 Aug; 107():396-410. PubMed ID: 27018450
[TBL] [Abstract][Full Text] [Related]
9. Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice.
Schier CJ; Marks WD; Paris JJ; Barbour AJ; McLane VD; Maragos WF; McQuiston AR; Knapp PE; Hauser KF
J Neurosci; 2017 Jun; 37(23):5758-5769. PubMed ID: 28473642
[TBL] [Abstract][Full Text] [Related]
10. Histamine Excites Striatal Dopamine D1 and D2 Receptor-Expressing Neurons via Postsynaptic H1 and H2 Receptors.
Zhuang QX; Xu HT; Lu XJ; Li B; Yung WH; Wang JJ; Zhu JN
Mol Neurobiol; 2018 Oct; 55(10):8059-8070. PubMed ID: 29498008
[TBL] [Abstract][Full Text] [Related]
11. Chemogenetic Silencing of Na
Haroun R; Gossage SJ; Luiz AP; Arcangeletti M; Sikandar S; Zhao J; Cox JJ; Wood JN
eNeuro; 2023 Sep; 10(9):. PubMed ID: 37679042
[TBL] [Abstract][Full Text] [Related]
12. Regional and cell-type-specific effects of DAMGO on striatal D1 and D2 dopamine receptor-expressing medium-sized spiny neurons.
Ma YY; Cepeda C; Chatta P; Franklin L; Evans CJ; Levine MS
ASN Neuro; 2012 Mar; 4(2):. PubMed ID: 22273000
[TBL] [Abstract][Full Text] [Related]
13. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.
Cepeda C; André VM; Yamazaki I; Wu N; Kleiman-Weiner M; Levine MS
Eur J Neurosci; 2008 Feb; 27(3):671-82. PubMed ID: 18279319
[TBL] [Abstract][Full Text] [Related]
14. Membrane properties of striatal direct and indirect pathway neurons in mouse and rat slices and their modulation by dopamine.
Planert H; Berger TK; Silberberg G
PLoS One; 2013; 8(3):e57054. PubMed ID: 23469183
[TBL] [Abstract][Full Text] [Related]
15. Chloride channels with ClC-1-like properties differentially regulate the excitability of dopamine receptor D1- and D2-expressing striatal medium spiny neurons.
Yarotskyy V; Lark ARS; Nass SR; Hahn YK; Marone MG; McQuiston AR; Knapp PE; Hauser KF
Am J Physiol Cell Physiol; 2022 Mar; 322(3):C395-C409. PubMed ID: 35080921
[TBL] [Abstract][Full Text] [Related]
16. Differential tonic GABA conductances in striatal medium spiny neurons.
Ade KK; Janssen MJ; Ortinski PI; Vicini S
J Neurosci; 2008 Jan; 28(5):1185-97. PubMed ID: 18234896
[TBL] [Abstract][Full Text] [Related]
17. Selective alterations of NMDAR function and plasticity in D1 and D2 medium spiny neurons in the nucleus accumbens shell following chronic intermittent ethanol exposure.
Renteria R; Maier EY; Buske TR; Morrisett RA
Neuropharmacology; 2017 Jan; 112(Pt A):164-171. PubMed ID: 26946430
[TBL] [Abstract][Full Text] [Related]
18. Loss of Plasticity in the D2-Accumbens Pallidal Pathway Promotes Cocaine Seeking.
Heinsbroek JA; Neuhofer DN; Griffin WC; Siegel GS; Bobadilla AC; Kupchik YM; Kalivas PW
J Neurosci; 2017 Jan; 37(4):757-767. PubMed ID: 28123013
[TBL] [Abstract][Full Text] [Related]
19. Nucleus accumbens medium spiny neuron subtypes mediate depression-related outcomes to social defeat stress.
Francis TC; Chandra R; Friend DM; Finkel E; Dayrit G; Miranda J; Brooks JM; Iñiguez SD; O'Donnell P; Kravitz A; Lobo MK
Biol Psychiatry; 2015 Feb; 77(3):212-222. PubMed ID: 25173629
[TBL] [Abstract][Full Text] [Related]
20. Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease.
Taverna S; Ilijic E; Surmeier DJ
J Neurosci; 2008 May; 28(21):5504-12. PubMed ID: 18495884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
